Your browser doesn't support javascript.
loading
Neutralizing immunity against coronaviruses in Tanzanian health care workers.
Barabona, Godfrey; Ngare, Isaac; Kamori, Doreen; Nkinda, Lilian; Kosugi, Yusuke; Mawazo, Ambele; Ekwabi, Rayi; Kinasa, Gloria; Chuwa, Harrison; Sato, Kei; Sunguya, Bruno; Ueno, Takamasa.
Affiliation
  • Barabona G; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Ngare I; Division of Infection and Immunity, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Kamori D; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Nkinda L; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
  • Kosugi Y; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Mawazo A; Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ekwabi R; Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kinasa G; Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Chuwa H; Amana Regional Referral Hospital, Dar es Salaam, Tanzania.
  • Sato K; Aga Khan Hospital, Dar es Salaam, Tanzania.
  • Ueno T; Collaboration Unit for Infection, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan.
Sci Rep ; 14(1): 5508, 2024 03 06.
Article de En | MEDLINE | ID: mdl-38448564
ABSTRACT
The ongoing vaccination efforts and exposure to endemic and emerging coronaviruses can shape the population's immunity against this group of viruses. In this study, we investigated neutralizing immunity against endemic and emerging coronaviruses in 200 Tanzanian frontline healthcare workers (HCWs). Despite low vaccination rates (19.5%), we found a high SARS-CoV-2 seroprevalence (94.0%), indicating high exposure in these HCWs. Next, we determined the neutralization capacity of antisera against human coronavirus NL63, and 229E, SARS-CoV-1, MERS-CoV and SARS-CoV-2 (including Omicron subvariants BA.1, BQ.1.1 and XBB.1.5) using pseudovirus neutralization assay. We observed a broad range of neutralizing activity in HCWs, but no neutralization activity detected against MERS-CoV. We also observed a strong correlation between neutralizing antibody titers for SARS-CoV-2 and SARS-CoV-1, but not between other coronaviruses. Cross-neutralization titers against the newer Omicron subvariants, BQ.1.1 and XBB.1.5, was significantly reduced compared to BA.1 and BA.2 subvariants. On the other hand, the exposed vaccinated HCWs showed relatively higher median cross-neutralization titers against both the newer Omicron subvariants and SARS-CoV-1, but did not reach statistical significance. In summary, our findings suggest a broad range of neutralizing potency against coronaviruses in Tanzanian HCWs with detectable neutralizing immunity against SARS-CoV-1 resulting from SARS-CoV-2 exposure.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Coronavirus humain NL63 / Coronavirus du syndrome respiratoire du Moyen-Orient Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Sci Rep Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Coronavirus humain NL63 / Coronavirus du syndrome respiratoire du Moyen-Orient Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Sci Rep Année: 2024 Type de document: Article Pays d'affiliation: Japon Pays de publication: Royaume-Uni